Company Filing History:
Years Active: 2024
Title: Emily Wright: Innovator in Vaccine Development
Introduction
Emily Wright is a prominent inventor based in Covina, California. She has made significant contributions to the field of vaccine development, particularly in the fight against COVID-19. Her innovative work focuses on creating effective adjuvanted vaccines that utilize modified proteins to enhance immune responses.
Latest Patents
Emily Wright holds a patent for "Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use." This patent discloses adjuvanted protein vaccines that comprise a modified S1 Spike protein sequence from the SARS-CoV-2 variant C.1.2, encapsulated within a non-phospholipid liposome. The vaccines are designed for subcutaneous administration, providing a novel approach to immunization against this variant. Additionally, the patent includes modified spike protein sequences and methods for utilizing these vaccines effectively.
Career Highlights
Emily is currently associated with D4 Labs, LLC, where she continues her research and development efforts. Her work has been instrumental in advancing vaccine technology, particularly during the ongoing pandemic. With her expertise, she has contributed to the understanding and application of modified spike proteins in vaccine formulations.
Collaborations
Emily collaborates with notable colleagues, including David Craig Wright and Michael Bowe. Their combined efforts in research and development have fostered innovation in the field of immunology and vaccine production.
Conclusion
Emily Wright's contributions to vaccine development exemplify the critical role of inventors in addressing global health challenges. Her innovative approach to creating effective vaccines against COVID-19 highlights the importance of scientific research and collaboration in the fight against infectious diseases.